Literature DB >> 22648291

Extraperitoneal laparoscopic retroperitoneal lymph node dissection after chemotherapy for nonseminomatous testicular germ-cell tumor: surgical and oncological outcomes.

Yoichi Arai1, Yasuhiro Kaiho, Shigeyuki Yamada, Hideo Saito, Koji Mitsuzuka, Shinichi Yamashita, Shunichi Namiki, Haruo Nakagawa, Shigeto Ishidoya, Akihiro Ito.   

Abstract

PURPOSE: To assess the surgical and oncological outcomes of laparoscopic retroperitoneal lymph node dissection (RPLND) after chemotherapy.
METHODS: Twenty patients with metastatic nonseminomatous testicular germ-cell tumor underwent extraperitoneal laparoscopic RPLND after chemotherapy. The procedure was not indicated for patients with a pre-chemotherapy mass larger than 5 cm. Morbidity and oncological outcome were reviewed retrospectively. Surgical complications were graded according to the Clavien classification system.
RESULTS: Laparoscopic RPLND was completed in all patients, and there was no conversion to open surgery. The median operating time was 223 min (range, 137-399 min). The median blood loss was 20 ml (range, 10-520 ml). There were no intraoperative complications. Postoperatively, 4 patients (20 %) had prolonged lymphorrhea (grade I) and 9 (45 %) had chyle leakage (grade I). Histological examination of the residual mass revealed necrosis in 16 (80 %) and the presence of teratoma with/without viable tumor in 4 (20 %). With a median follow-up of 45 months (range, 24-112), no patient has had disease recurrence. Normal antegrade ejaculation was preserved in all of the 14 patients studied.
CONCLUSIONS: Extraperitoneal laparoscopic RPLND can be performed with acceptable morbidity and excellent cancer control in select patients. Surgeons should be aware of relatively high incidence of chyle leakage following this procedure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22648291     DOI: 10.1007/s11255-012-0195-z

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  24 in total

1.  Laparoscopic retroperitoneal lymph node dissection in a patient with stage 1 testicular carcinoma.

Authors:  D B Rukstalis; G W Chodak
Journal:  J Urol       Date:  1992-12       Impact factor: 7.450

Review 2.  Controversial technology: the Chunnel and the laparoscopic retroperitoneal lymph node dissection (RPLND).

Authors:  Michael J Schwartz; Louis R Kavoussi
Journal:  BJU Int       Date:  2010-10       Impact factor: 5.588

3.  Laparoscopic retroperitoneal lymphadenectomy after chemotherapy for stage IIB nonseminomatous testicular carcinoma.

Authors:  G Janetschek; A Hobisch; A Hittmair; L Höltl; R Peschel; G Bartsch
Journal:  J Urol       Date:  1999-02       Impact factor: 7.450

4.  Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer: a model update and multicentre validation with more than 1000 patients.

Authors:  Yvonne Vergouwe; Ewout W Steyerberg; Richard S Foster; Dirk T Sleijfer; Sophie D Fosså; Arthur Gerl; Ronald de Wit; J Trevor Roberts; J Dik F Habbema
Journal:  Eur Urol       Date:  2006-07-14       Impact factor: 20.096

5.  Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: indications and limitations.

Authors:  J J Rassweiler; O Seemann; T O Henkel; C Stock; T Frede; P Alken
Journal:  J Urol       Date:  1996-09       Impact factor: 7.450

6.  Extraperitoneal laparoscopic para-aortic lymph node dissection for early stage nonseminomatous germ cell tumors of the testis with introduction of a nerve sparing technique: description and results.

Authors:  E LeBlanc; A Caty; D Dargent; D Querleu; E Mazeman
Journal:  J Urol       Date:  2001-01       Impact factor: 7.450

7.  Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?

Authors:  Stephen D W Beck; Richard S Foster; Richard Bihrle; John P Donohue; Lawrence H Einhorn
Journal:  Cancer       Date:  2007-09-15       Impact factor: 6.860

8.  Lymphatic mapping and gamma probe guided laparoscopic biopsy of sentinel lymph node in patients with clinical stage I testicular tumor.

Authors:  Chikara Ohyama; Yutaka Chiba; Tetsuro Yamazaki; Mareyuki Endoh; Senji Hoshi; Yoichi Arai
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

9.  Postchemotherapy laparoscopic retroperitoneal lymph node dissection in nonseminomatous germ-cell tumor.

Authors:  Jean-Patrice Calestroupat; Rafael Sanchez-Salas; Xavier Cathelineau; Francois Rozet; Marc Galiano; Gordon Smyth; Ali Kasraeian; Eric Barret; Guy Vallancien
Journal:  J Endourol       Date:  2009-04       Impact factor: 2.942

10.  Post-chemotherapy laparoscopic retroperitoneal lymph-node dissection in testis cancer patients.

Authors:  Rafael Maldonado-Valadez; David Schilling; Aristotelis G Anastasiadis; Wolfgang Sturm; Arnulf Stenzl; Stefan Corvin
Journal:  J Endourol       Date:  2007-12       Impact factor: 2.942

View more
  5 in total

1.  Trans- and extraperitoneal retroperitoneal lymph node dissection (RPLND) in the treatment for nonseminomatous germ cell testicular tumors (NSGCT): a single Chinese center's retrospective analysis.

Authors:  Shiyu Tong; Minfeng Chen; Xiongbing Zu; Yuan Li; Wei He; Ye Lei; Wentao Liu; Lin Qi
Journal:  Int Urol Nephrol       Date:  2013-09-01       Impact factor: 2.370

2.  Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.

Authors:  Terukazu Nakamura; Akihiro Kawauchi; Masakatsu Oishi; Takashi Ueda; Takumi Shiraishi; Hiroyuki Nakanishi; Kazumi Kamoi; Yoshio Naya; Fumiya Hongo; Koji Okihara; Tsuneharu Miki
Journal:  Int J Clin Oncol       Date:  2015-12-23       Impact factor: 3.402

3.  Laparoscopic retroperitoneal lymph node dissection versus open retroperitoneal lymph node dissection for testicular cancer: A comparison of clinical and perioperative outcomes.

Authors:  Toshihide Shishido; Takatsugu Okegawa; Kenjiro Hayashi; Kazuki Masuda; Satoru Taguchi; Yu Nakamura; Mitsuhiro Tambo; Hiroshi Fukuhara
Journal:  Asian J Urol       Date:  2021-05-25

4.  Retroperitoneoscopic Cutaneous Ureterostomy in the Supine Position to Relieve Painful Urinary-related Symptoms in an Advanced Anal Canal Cancer Patient.

Authors:  Akihiro Ito; Yasuhiro Kaiho; Yoichi Arai
Journal:  Urol Case Rep       Date:  2013-12-19

Review 5.  Extraperitoneal robot-assisted laparoscopic retroperitoneal lymph node dissection for early-stage testicular nonseminomatous germ cell tumors: A case report and literature review.

Authors:  Jie Qin; Ping Wang; Taile Jing; Debo Kong; Dan Xia; Shuo Wang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.